APP and Alzheimer disease: Further to this, when wild type amoeba were made to express a variant of human APP, the cells were clearly able to process APP in a manner identical to mammalian cells resulting in the differential production of C-terminal fragments and Aβ40/Aβ42, the toxic fragment believed to be the causative agent in AD (Figure 3).